These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36685888)

  • 1. Up-regulated PIF1 predicts poor clinical outcomes and correlates with low immune infiltrates in clear cell renal cell carcinoma.
    Cai T; Wang N; Meng P; Sun W; Cui Y
    Front Genet; 2022; 13():1058040. PubMed ID: 36685888
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
    Xie W; Xi P; Liu Y; Zhang Z; Sun T
    Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
    Zhang H; Liu Y; Wang B; Wang C
    BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
    Gan J; Zhang H
    Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma.
    Zheng B; Wang S; Yuan X; Zhang J; Shen Z; Ge C
    BMC Urol; 2023 May; 23(1):82. PubMed ID: 37138262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.
    Tong J; Meng X; Lv Q; Yuan H; Li W; Xiao W; Zhang X
    Int J Gen Med; 2021; 14():6587-6599. PubMed ID: 34703279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Wang X; Li W; Lou N; Han W; Hai B; Xiao W; Zhang X
    Pharmgenomics Pers Med; 2023; 16():1-14. PubMed ID: 36636625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
    Zhang C; Li Z; Qi F; Hu X; Luo J
    Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
    Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
    BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
    Zhong G; Li Q; Luo Y; Liu Y; Liu D; Li B; Wang T
    J Oncol; 2022; 2022():8943643. PubMed ID: 36059798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
    Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Front Oncol; 2021; 11():630706. PubMed ID: 33968730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.
    Liu Y; Zhang Z; Fu S; Wang S; Cheng X; Lei K; Li Z; Sun T; Ma M
    Int J Gen Med; 2021; 14():6741-6754. PubMed ID: 34675634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].
    Cai TY; Zhu ZP; Xu CR; Ji X; Lv TD; Guo ZK; Lin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):628-635. PubMed ID: 35950384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
    Zhang WT; Gong YM; Zhang CY; Pan JS; Huang T; Li YX
    Biomed Res Int; 2022; 2022():9196540. PubMed ID: 36105937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
    Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.